bpc 157 and ulcerative colitis Does BPC-157 Aid Inflammatory Bowel Disease? BPC 157 update | Crohn’s

Drugs are not inherently bad but this comes at a high cost with dubious efficacy: - $1,500-3,000 in annual out-of-pocket costs per person - 1.5M ER visits yearly from adverse drug interactions - Higher risks of kidney, liver and other bodily injuries For #healthcare founders and operators, theres an important opportunity to improve lives while bringing down costs for everyone

Growth Factor and Cellular Proliferation Pathways BPC-157 appears to upregulate several pro-survival and pro-proliferation pathways essential for tissue repair

Reduces Inflammation

Common symptoms include a noticeable bulge in the affected area, discomfort or pain, especially when lifting or straining, and a feeling of heaviness

Nausea is the most frequently reported adverse effect, potentially affecting thirty to forty percent of patients at some point during treatment, though the intensity typically diminishes over time as tolerance develops